A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort Turbuhaler.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms Symb-NIS
- Sponsors AstraZeneca
- 10 Jun 2009 Trial acronym Symb-NIS added as reported by ClinicalTrials.gov.
- 10 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2009 Actual end date (1 Nov 2007) added as reported by ClinicalTrials.gov.